U.S. Pharma Stock News

Vita Coco Company (COCO) has been drawing fresh attention after its latest quarterly report, which showed revenue up 37.2% year on year and EBITDA well ahead of analyst estimates, with the stock rising 23.6% since. See our latest analysis for Vita Coco Company. Those quarterly numbers arrived on top of an already strong run, with a 90 day share price return of 30.71% and a 1 year total shareholder return of 54.74%. Newer efforts in sports hydration marketing and a recent board appointment...

Management succession move puts leadership in focus First Financial Bankshares (FFIN) recently announced a series of executive promotions at its First Financial Bank subsidiary, as part of a broader management succession plan that highlights leadership development, regional responsibilities, and continuity for shareholders. See our latest analysis for First Financial Bankshares. The succession announcements arrive after a period where the share price has shown steady positive momentum in the...

Macy’s has in recent months accelerated its “bold new chapter” transformation, closing underproductive stores and Connecticut distribution centers, cutting more than 1,000 jobs, and reallocating investment toward higher‑performing locations and a new North Carolina fulfillment facility while Bloomingdale’s pursues experiential partnerships like its “Wuthering Heights” promotion. Taken together, these moves point to Macy’s reshaping itself into a leaner retailer with a streamlined store base...

Recent US policy shifts toward Venezuela have put Helmerich & Payne (HP) back in focus, as investors weigh what potential access to Venezuelan oil reserves and any recovery of seized rigs and unpaid invoices could mean for the stock. See our latest analysis for Helmerich & Payne. The Venezuela headlines have arrived at a time when momentum in Helmerich & Payne’s share price has been picking up, with a 30 day share price return of 15.60% and a 90 day share price return of 40.11%. This is...

In recent days, Akamai Technologies has attracted increased attention as multiple analysts upgraded their ratings and revised their outlooks following a period of slower revenue growth but improving profitability metrics. These shifts highlight a growing focus on Akamai’s security and compute businesses as key drivers of profit-focused execution, while the company prepares to report its fourth quarter and full-year 2025 results next month. Next, we’ll explore how this wave of analyst...

Recent analyst upgrades for Prologis (PLD), including a move to Sector Outperform at Scotiabank, are arriving just as the company heads into an earnings report with mixed expectations. See our latest analysis for Prologis. At a share price of $133.21, Prologis has logged a 30 day share price return of 4.01% and a 90 day gain of 7.36%. The 1 year total shareholder return of 26.01% and 5 year total shareholder return of 51.39% point to momentum that has been building rather than fading. If...

Takeda collaboration puts ENHANZE platform in focus Halozyme Therapeutics (HALO) has drawn fresh attention after a global collaboration and exclusive license agreement with Takeda, giving Takeda access to Halozyme’s ENHANZE drug delivery technology for vedolizumab in inflammatory bowel disease. See our latest analysis for Halozyme Therapeutics. While the Takeda agreement has put Halozyme back in the spotlight, the share price tells a mixed short term story. There has been a 1 day share price...

DTE Energy (DTE) is back in focus after reaffirming its 2025 adjusted EPS guidance, outlining an early 2026 outlook, and securing a 1.4 GW data center agreement that has drawn fresh regulatory scrutiny. See our latest analysis for DTE Energy. The reaffirmed 2025 guidance, early 2026 outlook and the 1.4 GW data center agreement all arrive as DTE Energy’s share price sits at US$135.51. The 30 day share price return is 5.14% and the 1 year total shareholder return is 13.28%, suggesting momentum...

Onto Innovation’s leadership recently presented at the 28th Annual Needham Growth Conference in New York, outlining its semiconductor process control roadmap and positioning within advanced packaging and AI-related manufacturing trends. At the same time, the company has attracted growing institutional interest and options activity as analysts highlight its role in meeting tightening advanced packaging capacity needs. We’ll now examine how this strengthening analyst optimism around AI-driven...

Xencor (XNCR) recently outlined 2026 priorities for its XmAb platform, highlighting early clinical data for renal cell carcinoma candidate XmAb819 and setting out timelines for multiple oncology and autoimmune milestones that could influence investor expectations. See our latest analysis for Xencor. Despite the fresh 2026 pipeline update, Xencor’s recent share price momentum has been weak, with a 30 day share price return of a 19.05% decline and a 1 year total shareholder return of a 33.52%...

In mid-January 2026, High Roller Technologies, Inc. announced a binding Letter of Intent with Crypto.com | Derivatives North America to power a regulated, event-based prediction markets product in the United States, alongside multiple non-binding marketing LOIs with social-first sports media platforms to support its planned launch. A distinctive aspect of this move is High Roller’s effort to pair regulated prediction-market infrastructure with billion-scale social media reach from partners...

WD-40 (WDFC) is back in focus after its latest quarter showed flat sales and lower GAAP profit, tied mainly to timing issues with Asia Pacific distributors rather than a pullback in underlying demand. See our latest analysis for WD-40. That backdrop helps explain recent trading, with the share price at US$204.99 after a 7 day share price return of 7.89% and a 90 day share price return of 5.40%. At the same time, the 1 year total shareholder return is 9.92% lower and the 3 year total...

Harmony Biosciences Holdings recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, where CEO Jeffrey M. Dayno outlined the company’s latest business and pipeline updates. The company underscored its expectation that WAKIX could achieve more than US$1.00 billion in 2026 revenue while advancing next-generation pitolisant formulations and additional CNS programs to extend the franchise and diversify growth. We’ll now examine how Harmony’s blockbuster WAKIX...

LXP Industrial Trust (LXP) has overhauled its debt profile by closing a new US$600 million senior unsecured revolving credit facility and refinancing a US$250 million unsecured term loan with longer maturities and lower stated borrowing costs. See our latest analysis for LXP Industrial Trust. The financing update comes after a period of steady share price momentum, with LXP Industrial Trust’s 90 day share price return of 8.30% and year to date share price return of 3.43%, while the 1 year...

Why Centuri Holdings Is On Investors’ Radar Centuri Holdings (CTRI) has drawn fresh attention after recent trading, with the stock showing positive moves over the past week, month and past 3 months, prompting investors to reassess its utility infrastructure-focused story. See our latest analysis for Centuri Holdings. At a share price of $27.80, Centuri’s recent 4.2% 1 day share price return and 10.6% 30 day share price return contribute to a 90 day move of 38.2%, while the 1 year total...

Why the new a16z partnership matters for Booz Allen Hamilton Holding (BAH) Booz Allen Hamilton Holding (BAH) just became Andreessen Horowitz’s first Technology Acceleration Partner for Governments, tying its federal mission work directly to a16z portfolio companies focused on AI, cybersecurity, autonomy, and electronic warfare. For you as an investor, this collaboration connects Booz Allen’s government reach and technical know how with growth stage startups that are working on tools for...

On 14 January 2026, Concentra Group Holdings Parent, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, outlining its business performance and financial framework to investors. The company underscored its role as a leading U.S. occupational health provider, treating roughly one in four workplace injuries across more than 1,000 locations while relying on non‑GAAP metrics such as Adjusted EBITDA and ROIC to assess performance and capital allocation. Next,...

Hawaiian Electric Industries (HE) is back in focus after reaching preliminary agreements to settle eight shareholder lawsuits tied to wildfire risk disclosures, funded by US$100 million in insurance proceeds and accompanied by new Hawaii wildfire legislation. See our latest analysis for Hawaiian Electric Industries. The wildfire settlement progress and new Hawaii legislation arrive after a sharp rebound in sentiment, with a 20.72% 1 month share price return and a 58.10% 1 year total...

Why analyst downgrades have put American Homes 4 Rent in focus Several major Wall Street firms recently lowered their views on American Homes 4 Rent (AMH). This has pushed the stock higher on many investors’ watchlists and raised fresh questions about the REIT’s current pricing. See our latest analysis for American Homes 4 Rent. At a share price of $32.36, American Homes 4 Rent has seen short term momentum pick up, with a 1-day share price return of 2.02% and a 7-day share price return of...

Recent performance snapshot Advanced Drainage Systems (WMS) has drawn fresh attention after a period of steady share moves, with the stock recently closing at $159.30 and posting positive returns over the past month and past 3 months. See our latest analysis for Advanced Drainage Systems. Beyond the recent share price move, Advanced Drainage Systems has built a clear upswing, with a 10.1% 30 day share price return alongside a 27.6% 1 year total shareholder return. This suggests momentum has...

If you are wondering whether TD SYNNEX at around US$150 is a fair deal or starting to look stretched, this article walks through what the current price might be implying about the company. The stock has been relatively steady in the near term, with a 0.3% decline over the last 7 days and a 0.7% gain over the last 30 days, while the 1 year return sits at 11.2% and the 3 and 5 year returns at 43.4% and 78.0% respectively. Recent coverage around TD SYNNEX has focused on its position as a large...

If you are looking at Centene and wondering whether the recent price is fair or not, this article walks through what the current share price might imply about the company's value. Centene's share price recently closed at US$45.75, with a 30 day return of 17.7% and a 1 year return showing a 26.5% decline, which may change how investors think about its risk and potential. Recent coverage around Centene has focused on its role as a major managed care player and how policy developments and...

Arbor Realty Trust announced that long-serving director Joseph Martello retired from its Board on December 31, 2025, and was replaced on January 5, 2026, by Mr. Natalone as a Class II director to fill the resulting vacancy. This Board transition comes as Arbor Realty Trust is working through elevated borrower delinquencies and challenging loan restructurings on its 2021–2022 vintage portfolio, adding governance change to an already complex operating backdrop. With the Board refresh occurring...

Why Willdan Group (WLDN) Is Back on Investors’ Radar Willdan Group (WLDN) has been in focus after completing its acquisition of Compass Municipal Advisors and winning a US$97 million energy savings performance contract with Alameda County, California, covering upgrades across 24 county sites. See our latest analysis for Willdan Group. Investors appear to be reacting to this mix of new contracts and an expanded municipal finance platform, with a 29.12% 1 month share price return and a very...